If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,804.00    -100.00 (-3.44%)
Bid:
2,760.00
Ask:
2,766.00
Spread: 6.00 (0.217%)
Market Cap: £1.54b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Acquisition

17 Dec 2012 07:00

RNS Number : 6368T
Oxford Instruments PLC
17 December 2012
 



Embargoed until 7am, 17 December 2012

 

Oxford Instruments plc: Acquisition of Asylum Research Corp.

 

Oxford Instruments plc ("Oxford Instruments" or "the Group"), a leading provider of high technology tools and systems for industry and research, announces the acquisition of Asylum Research Corporation ("Asylum Research"), a leading provider of Scanning Probe Microscopes (SPM). The acquisition is subject to customary conditions and is expected to be completed before the end of December 2012.

 

Asylum Research is an established US company based in Santa Barbara, California, with subsidiaries in the UK, Germany and Taiwan. Its SPM technology is used to image and characterise the properties of surfaces and structures down to the atomic scale providing invaluable information to enable development and exploitation at the nanoscale. Its products are used by academic and industrial customers across the world for a wide range of materials and bioscience applications. The combination of Oxford Instruments and Asylum Research strengthens the Group's Nanotechnology Tools sector. SPM is a fundamental nanotechnology measurement technique and complements the existing portfolio of products and technologies within the Group.

 

Asylum Research is being acquired from its management for an initial debt free, cash free consideration of US$32.0 million with a deferred element of up to US$48.0 million payable over three years dependent on its performance over that period. Asylum Research generated Earnings Before Interest and Taxation (EBIT) of $1.1 million in the twelve months to 31 December 2011 from revenue in the same period of $19.6 million. It had gross assets of $6.2 million as at 31 December 2011. The acquisition will be funded from existing facilities.

 

The acquisition of Asylum Research is in line with Oxford Instruments' 14 Cubed objectives, to achieve a 14% average compound annual growth rate in revenues and a 14% return on sales by the year ending March 2014. This acquisition contributes to the planned acquisition element of the revenue growth objective. While Asylum Research is expected to deliver less than the 14% targeted margin in this and the next financial year, following the acquisition the 14 Cubed margin target for the Group remains unchanged.

 

As part of Oxford Instruments there will be significant scope to accelerate the inherent strong growth of Asylum Research's end markets and to deliver substantial improvements in margin over time based on increasing scale. Approximately 60% of Asylum Research turnover comes from customers working in the materials science area where the customer base and routes to market are shared with Oxford Instruments. This opens opportunities for market synergies and the development of new integrated products. The remainder of Asylum Research's turnover is in the bio-nano area where SPM instruments are used for research into soft materials, such as DNA. This market provides a new growth opportunity for Oxford Instruments.

 

 Commenting on the acquisition, Jonathan Flint, Chief Executive of Oxford Instruments, stated:

 

"The acquisition of Asylum Research significantly increases our footprint in the nanotechnology space and complements our strong position in electron microscopes with a presence in another fundamental nanotechnology measurement technique. The acquisition also gives us access to the rapidly growing bio-nano market as it allows customers to perform analysis of organic samples in their natural liquid environments, something which cannot readily be done using electron microscopes."

 

A conference call for analysts and investors will be held at 08.30 (UK time) today to discuss this statement.

 

Participant Access Details:

Toll Number +44 203 139 4830

Toll-Free Number 0808 237 0030

Participant PIN Code 81210256#

 

- Ends -

 

Issued for and on behalf of Oxford Instruments plc

For further information please contact:

 

Oxford Instruments Plc

+44 (0)1865 393200

Jonathan Flint, Chief Executive

Kevin Boyd, Group Finance Director

 

MHP Communications

Rachel Hirst

Ian Payne

 

 

 

 

+44 (0) 20 3128 8100

Notes to Editors  

 

About Oxford Instruments plc

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. It provides solutions needed to advance fundamental physics research and its transfer into commercial nanotechnology applications. Innovation has been the driving force behind Oxford Instruments' growth and success for over 50 years, and its strategy is to effect the successful commercialisation of these ideas by bringing them to market in a timely and customer-focused fashion. 

The first technology business to be spun out from Oxford University over fifty years ago, Oxford Instruments is now a global company with over 2000 staff worldwide and is listed on the FTSE250 index of the London Stock Exchange (OXIG).  Its objective is to be the leading provider of new generation tools and systems for the research and industrial sectors.

This involves the combination of core technologies in areas such as low temperature, high magnetic field and ultra high vacuum environments, Nuclear Magnetic Resonance, X-ray, electron and optical based metrology, and advanced growth, deposition and etching.

Oxford Instruments aims to pursue responsible development and deeper understanding of our world through science and technology. Its products, expertise, and ideas address global issues such as energy, environment, security and health.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
ACQEADAKFAPAFAF
Date   Source Headline
10th Nov 20153:23 pmPRNHolding(s) in Company
10th Nov 20157:01 amRNSDirectorate Changes
10th Nov 20157:00 amRNSHalf Yearly Report
27th Oct 201510:06 amRNSReplacement re: Directorate Change
27th Oct 20157:00 amRNSDirectorate Change
14th Oct 201511:09 amPRNDirector/PDMR Shareholding
14th Sep 20159:59 amPRNDirector/PDMR Shareholding
8th Sep 20155:32 pmPRNResult of AGM
8th Sep 20157:00 amRNSAGM Statement
1st Sep 201510:03 amPRNTotal Voting Rights
11th Aug 20153:34 pmPRNDirector/PDMR Shareholding
6th Aug 20158:51 amPRNHolding(s) in Company
24th Jul 201512:47 pmPRNDirector/PDMR Shareholding
6th Jul 201511:58 amPRNTotal Voting Rights
23rd Jun 20154:42 pmPRNDirector/PDMR Shareholding
15th Jun 20152:40 pmPRNDirector/PDMR Shareholding
12th Jun 201510:08 amPRNDirector/PDMR Shareholding
9th Jun 20157:00 amRNSFinal Results
28th May 20157:00 amRNSNotice of Results
28th May 20157:00 amRNSJV for Oxford Instruments' Omicron business
21st May 20153:42 pmPRNHolding(s) in Company
13th May 201511:23 amPRNDirector/PDMR Shareholding
11th May 201511:45 amPRNDirector/PDMR Shareholding
1st May 20157:00 amRNSAcquisition
15th Apr 20151:45 pmPRNHolding(s) in Company
15th Apr 20157:00 amRNSTrading Statement
14th Apr 20151:03 pmPRNDirector/PDMR Shareholding
18th Mar 201512:20 pmPRNHolding(s) in Company
12th Mar 20153:12 pmPRNDirector/PDMR Shareholding
2nd Mar 20157:00 amRNSAmendment to existing bank facilities
12th Feb 20159:35 amPRNDirector/PDMR Shareholding
2nd Feb 201510:03 amPRNHolding(s) in Company
28th Jan 20152:26 pmPRNHolding(s) in Company
26th Jan 20153:59 pmPRNHolding(s) in Company
22nd Jan 20157:00 amRNSTrading Statement
20th Jan 20154:51 pmPRNHolding(s) in Company
15th Jan 201511:28 amPRNHolding(s) in Company
15th Jan 201511:06 amPRNDirector/PDMR Shareholding
6th Jan 201510:53 amPRNBlocklisting - Interim Review
6th Jan 201510:40 amPRNTotal Voting Rights
23rd Dec 201410:35 amPRNHolding(s) in Company
12th Dec 20149:34 amPRNDirector/PDMR Shareholding
8th Dec 201411:21 amPRNTotal Voting Rights
3rd Dec 201411:32 amPRNAdditional Listing
19th Nov 20149:24 amPRNHolding(s) in Company
18th Nov 20142:11 pmPRNAdditional Listing
13th Nov 20149:44 amPRNHolding(s) in Company
12th Nov 20141:33 pmPRNHolding(s) in Company
11th Nov 20143:49 pmPRNDirector/PDMR Shareholding
11th Nov 20149:51 amPRNHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.